Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2017 1
2018 1
2019 3
2020 2
2021 3
2022 4
2023 5
2024 6
2025 7
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.
Fettiplace A, Regev A, Kiazand A, Heinzel-Pleines U, Bahjat M, Garg A, Kikuchi L, Li H, Hamidi A, Alpers DH, Tillmann H, Larrey D, Di Bisceglie AM, Lewis JH. Fettiplace A, et al. Among authors: hamidi a. Drug Saf. 2025 Dec 4. doi: 10.1007/s40264-025-01635-5. Online ahead of print. Drug Saf. 2025. PMID: 41345813 Review.
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study.
Paulson KG, Lau SCM, Ahn MJ, Moskovitz M, Pogorzelski M, Häfliger S, Parkes A, Zhang Y, Hamidi A, Thompson CG, Wermke M. Paulson KG, et al. Among authors: hamidi a. Lancet Oncol. 2025 Oct;26(10):1300-1311. doi: 10.1016/S1470-2045(25)00480-2. Epub 2025 Sep 8. Lancet Oncol. 2025. PMID: 40934933 Clinical Trial.
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM; DeLLphi-304 Investigators. Mountzios G, et al. Among authors: hamidi a. N Engl J Med. 2025 Jul 24;393(4):349-361. doi: 10.1056/NEJMoa2502099. Epub 2025 Jun 2. N Engl J Med. 2025. PMID: 40454646 Clinical Trial.
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma.
Hecht JR, Oberoi A, Garralda Cabanas E, Jae Chon H, Digklia A, Rottey S, Martin Jimenez M, Chaney M, Hippenmeyer J, Lawrence T, Liu K, Hamidi A, Chesney J. Hecht JR, et al. Among authors: hamidi a. Oncologist. 2025 Mar 10;30(3):oyae203. doi: 10.1093/oncolo/oyae203. Oncologist. 2025. PMID: 40156118 Free PMC article. Clinical Trial.
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Sands JM, Champiat S, Hummel HD, Paulson KG, Borghaei H, Alvarez JB, Carbone DP, Carlisle JW, Choudhury NJ, Clarke JM, Gadgeel SM, Izumi H, Navarro A, Lau SCM, Lammers PE, Huang S, Hamidi A, Mukherjee S, Owonikoko TK. Sands JM, et al. Among authors: hamidi a. Cancer. 2025 Feb 1;131(3):e35738. doi: 10.1002/cncr.35738. Cancer. 2025. PMID: 39876075 Free PMC article. Review.
Survival Analysis of Glioblastoma: A Scientometric Perspective.
Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S, Hamidi A. Alirezaei Z, et al. Among authors: hamidi a. World Neurosurg. 2025 Feb;194:123476. doi: 10.1016/j.wneu.2024.11.059. Epub 2024 Dec 6. World Neurosurg. 2025. PMID: 39577630 Free article.
Exploring the OTITIS Research Landscape Through a Scientometric Approach.
Akhlaghi A, Hashemi SB, Hamidi A, Khosravi A, Jahangiri R. Akhlaghi A, et al. Among authors: hamidi a. Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1697-1710. doi: 10.1007/s12070-023-04387-9. Epub 2023 Dec 9. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 38566640 Free PMC article.
26 results